Objective The coronavirus disease 2019 (COVID-19) pandemic has demonstrated the value of real-world data for public health research. International federated analyses are crucial for …
Objective To quantify the comparative risk of thrombosis with thrombocytopenia syndrome or thromboembolic events associated with use of adenovirus based covid-19 vaccines versus …
Background Adverse events of special interest (AESIs) were pre-specified to be monitored for the COVID-19 vaccines. Some AESIs are not only associated with the vaccines, but with …
World Health Organization - 2023 - books.google.com
Thrombotic Thrombocytopenia Syndrome (TTS) has emerged as a new adverse event following immunization in individuals vaccinated with COVID-19 non-replicant adenovirus …
F Struyf, K Hardt, R Van Rampelbergh, G Shukarev… - Vaccine, 2023 - Elsevier
Background Thrombosis with thrombocytopenia syndrome (TTS) is a very rare disorder described after vaccination with adenoviral vector-based COVID-19 vaccines. Co-occurring …
AF Markus, VY Strauss, E Burn, X Li… - Frontiers in …, 2023 - frontiersin.org
Background: Thrombosis with thrombocytopenia syndrome (TTS) has been identified as a rare adverse event following some COVID-19 vaccines. Various guidelines have been …
PC Lloyd, B Lufkin, K Moll, RP Ogilvie… - Vaccine, 2024 - Elsevier
Background Increased risk of thrombosis with thrombocytopenia syndrome (TTS) following adenovirus vector-based COVID-19 vaccinations has been identified in passive surveillance …
Objective: This paper introduces a novel framework for evaluating phenotype algorithms (PAs) using the open-source tool, Cohort Diagnostics. Materials and Methods: The method …
A growing body of evidence generated from observational data has demonstrated the potential to influence decision-making and improve patient outcomes. For observational …